Natalizumab in Multiple Sclerosis: Long-Term Management

Natalizumab is a monoclonal antibody highly effective in the treatment of relapsing remitting multiple sclerosis (RRMS) patients. Despite its effectiveness, there are growing concerns regarding the risk of progressive multifocal leukoencephalopathy (PML), a brain infection caused by John Cunningham...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Mol Sci
Main Authors: Clerico, Marinella, Artusi, Carlo Alberto, Di Liberto, Alessandra, Rolla, Simona, Bardina, Valentina, Barbero, Pierangelo, De Mercanti, Stefania Federica, Durelli, Luca
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2017
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5454853/
https://ncbi.nlm.nih.gov/pubmed/28468254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18050940
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares